168 related articles for article (PubMed ID: 22938703)
1. Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections.
Erdurman FC; Pellumbi A; Durukan AH
Ophthalmic Surg Lasers Imaging; 2012 Aug; 43 Online():e87-9. PubMed ID: 22938703
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
3. Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections.
Lecleire-Collet A; Offret O; Gaucher D; Audren F; Haouchine B; Massin P
Acta Ophthalmol Scand; 2007 Nov; 85(7):795-8. PubMed ID: 17459030
[TBL] [Abstract][Full Text] [Related]
4. Lamellar macular hole formation in patients with diabetic cystoid macular edema.
Unoki N; Nishijima K; Kita M; Oh H; Sakamoto A; Kameda T; Hayashi H; Yoshimura N
Retina; 2009 Sep; 29(8):1128-33. PubMed ID: 19491719
[TBL] [Abstract][Full Text] [Related]
5. Angioedema after intravitreal bevacizumab injection.
Toklu Y; Sarac O; Berk S; Simsek S
Cutan Ocul Toxicol; 2012 Mar; 31(1):85-6. PubMed ID: 22309281
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of cystoid macular edema with bevacizumab in course of Irvine-Gass syndrome].
Izdebski B; Michalewska Z; Dziegielewski K; Nawrocki J; Odrobina D
Klin Oczna; 2013; 115(1):61-4. PubMed ID: 23882744
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab intravitreal injections in the treatment of diabetic macular oedema.
Małgorzata W; Diana D; Agnieszka B; Zofia M
Klin Oczna; 2013; 115(1):15-9. PubMed ID: 23882733
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
11. Macular hole after intravitreal bevacizumab injection for choroidal neovascularisation.
Tufan HA; Gencer B; Kara S
Clin Exp Optom; 2014 Mar; 97(2):178-80. PubMed ID: 23331251
[TBL] [Abstract][Full Text] [Related]
12. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
Rahman HT; Yeh S; Bergstrom CS
J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
[TBL] [Abstract][Full Text] [Related]
13. Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema.
Lee YJ; Kim M
Korean J Ophthalmol; 2019 Apr; 33(2):198-199. PubMed ID: 30977331
[No Abstract] [Full Text] [Related]
14. Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.
Soliman W; Vinten M; Sander B; Soliman KA; Yehya S; Rahman MS; Larsen M
Acta Ophthalmol; 2008 Jun; 86(4):365-71. PubMed ID: 18028237
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.
Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L;
Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901
[TBL] [Abstract][Full Text] [Related]
16. Lamellar macular hole following intravitreal pegaptanib sodium (Macugen) injection for diabetic macular edema.
Querques G; Bux AV; Iaculli C; Noci ND
Int Ophthalmol; 2011 Dec; 31(6):525-7. PubMed ID: 22203375
[TBL] [Abstract][Full Text] [Related]
17. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
Lim JW; Lee HK; Shin MC
Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
